TY - JOUR
T1 - Towards a "prescribing license" for medical students
T2 - development and quality evaluation of an assessment for safe prescribing
AU - Jansen, David R. M.
AU - Keijsers, Carolina J. P. W.
AU - Kornelissen, Michiel O.
AU - Rikkert, Marcel G. M. Olde
AU - Kramers, Cornelis
AU - Tichelaar, J.
AU - Janssen, B.
AU - van den Brink, A. Maassen
AU - Peeters, L.
AU - Dumont, G.
AU - Hessel, M.
AU - Rissmann, R.
AU - Knol, W.
AU - Education working group of the Dutch Society for Clinical Pharmacology and Biopharmacy
N1 - Funding Information:
The assessment was developed by the education working group of the Dutch Society for Clinical for Clinical Pharmacology and Biopharmacy: J. Tichelaar (VU University Medical Center, Amsterdam), B. Janssen (Maastricht University Medical Center), A. Maassen van den Brink and L. Peeters (Erasmus Medical Center, Rotterdam), G. Dumont (Amsterdam Medical Center, Amsterdam), M. Hessel and R. Rissmann (Leiden University Medical Center, Leiden), and W. Knol (Utrecht Medical Center, Utrecht).
Publisher Copyright:
© 2019, The Author(s).
PY - 2019/9
Y1 - 2019/9
N2 - Purpose This report describes the development and validation process of an assessment with national consensus in appropriate and safe pharmacotherapy. Methods A question-database on safe prescription based on literature of pharmacotherapy-related harm was developed by an expert group from Dutch medical faculties. Final-year medical students concluded a 2-year education program on appropriate and safe prescription by one of nine assessment variants of 40 multiple-choice questions each. An expert panel of professionals (n = 10) answered all database questions and rated questions on relevance. Questions were selected for revision based on lack of relevance or poor test and item characteristics. Results A total of 576 final-year medical students of the Radboud University was assessed. There was no significant difference in performance between students and content expert group (p = 0.7), probably due to learning behavior. Out of 165 questions, 59 were selected for revision. Conclusion Joint national effort from a team of experts in prescription and pharmacotherapy is an appropriate way to achieve a valid and reliable last-year student drug prescription assessment.
AB - Purpose This report describes the development and validation process of an assessment with national consensus in appropriate and safe pharmacotherapy. Methods A question-database on safe prescription based on literature of pharmacotherapy-related harm was developed by an expert group from Dutch medical faculties. Final-year medical students concluded a 2-year education program on appropriate and safe prescription by one of nine assessment variants of 40 multiple-choice questions each. An expert panel of professionals (n = 10) answered all database questions and rated questions on relevance. Questions were selected for revision based on lack of relevance or poor test and item characteristics. Results A total of 576 final-year medical students of the Radboud University was assessed. There was no significant difference in performance between students and content expert group (p = 0.7), probably due to learning behavior. Out of 165 questions, 59 were selected for revision. Conclusion Joint national effort from a team of experts in prescription and pharmacotherapy is an appropriate way to achieve a valid and reliable last-year student drug prescription assessment.
KW - Prescribing
KW - Medication safety
KW - Education
KW - FREQUENCY
KW - HARM
U2 - 10.1007/s00228-019-02686-1
DO - 10.1007/s00228-019-02686-1
M3 - Article
C2 - 31104076
SN - 0031-6970
VL - 75
SP - 1261
EP - 1268
JO - European Journal of Clinical Pharmacology
JF - European Journal of Clinical Pharmacology
IS - 9
ER -